AI assistant
BIOGEN INC. — Director's Dealing 2012
Dec 28, 2012
30291_dirs_2012-12-28_a5ccc317-3245-4cdd-93b0-b010714746bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-12-26
Reporting Person: DENNER ALEXANDER J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-26 | Common Stock | S | 3989 | $148.888 | Disposed | 8911 | Direct |
| 2012-12-27 | Common Stock | S | 2691 | $148.022 | Disposed | 6220 | Direct |
| 2012-12-27 | Common Stock | S | 1300 | $149.045 | Disposed | 4920 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $148.20 (low) and $149.15 (high).
F4: This represents the weighted average price for shares sold at a range between $147.70 (low) and $148.66 (high).
F5: This represents the weighted average price for shares sold at a range between $148.71 (low) and $149.49 (high).